BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $4.39 | Prev. Close $4.43 | Circuit Range N/A |
Day Range $4.39 - $4.59 | Year Range $0.61 - $13.78 | Volume 2,433 |
Average Traded $4.52 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-Apr-26 | $4.19 | $4.42 | +2.31% |
06-Apr-26 | $4.11 | $4.32 | +4.85% |
02-Apr-26 | $4.01 | $4.12 | -0.24% |
01-Apr-26 | $4.22 | $4.13 | -1.67% |
31-Mar-26 | $4.29 | $4.20 | +2.69% |
30-Mar-26 | $3.77 | $4.09 | +9.36% |
27-Mar-26 | $3.89 | $3.74 | -3.86% |